Table 2 Plasma bile salt species in 0.03% cholic acid-fed mice
WT (n=3) | Hrn (n=10) | Atp8b1G308V/G308V (n=4) | Atp8b1G308V/G308V/Hrn (n=6) | Abcb4−/− (n=8) | Abcb4−/−/Hrn (n=5) | |
|---|---|---|---|---|---|---|
Plasma total bile salts (μ M) | 4.1±2.2 | 3.9±1.0 | 187.8±70.1 | 764.7±264.0 | 6.3±1.5 | 840.4±496.0 |
Species (% of total) | ||||||
Tauro-α-muricholate | 14.4±8.3 | 6.3±1.6 | 10.9±7.8 | 1.2±0.9 | 0.7±0.2 | 2.1±0.6 |
Tauro-β-muricholate | 11.9±6.9 | 21.5±5.0 | 22.8±1.5 | 12.3±4.8 | 20.2±2.7 | 8.7±4.2 |
Tauroursodeoxycholate | 0.4±0.2 | 0.3±0.2 | 1.1±1.0 | 0.4±0.2 | 1.7±0.9 | 4.0±3.9 |
Taurocholate | 71.3±2.3 | 52.7±7.3 | 47.8±16.1 | 81.9±7.4 | 46.9 ±7.0 | 76.4±8.8 |
Taurochenodeoxycholate | n.d. | 3.1±2.1 | 0.6±0.5 | 1.2±1.0 | n.d. | 1.9±1.2 |
Ω-Muricholate | n.d. | 0.9±0.7 | 0.9±0.6 | n.d. | 0.4±0.4 | 1.6±1.2 |
Taurodeoxycholate | n.d. | 13.0±6.1 | 1.2±1.2 | 0.3±0.2 | 13.6±6.9 | 5.1±4.0 |
α-Muricholate | n.d. | 0.7±0.7 | 1.2±0.7 | 0.1±0.02 | n.d. | n.d. |
β-Muricholate | n.d. | n.d. | 5.5±3.2 | 0.2±0.09 | n.d. | 0.1±0.01 |
Cholate | 1.9±1.1 | 1.4±1.4 | 8.0±4.2 | 1.6±0.6 | n.d. | 0.1±0.08 |
Chenodeoxycholate | n.d. | n.d. | n.d. | 0.7±0.9 | 16.5±3.9 | 0.1±0.08 |
Deoxycholate | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. |
Hydrophobicity index | −0.21±0.1 | −0.13 ±0.06 | −0.20±0.005 | −0.06±0.02a | 0.03±0.09 | −0.06±0.06b |